PTSD Trial, Recruiting NCT05486793 Sponsor: Boston University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05486793
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Pregnant women who are receiving prenatal care at the BMC Obstetrics and Gynecology (OB/GYN) Department
  • Women who started prenatal care before 28 weeks of pregnancy
  • Women who have symptoms of PTSD (post-traumatic stress disorder), either meeting the full diagnosis or having enough symptoms to be close to a diagnosis, as measured by a specific clinical interview tool

Who may not be able to join:

  • People whose doctor feels they need a higher level of care, such as a detox program, inpatient hospital stay, or residential treatment, rather than outpatient care
  • People who have been diagnosed with psychosis or unstable bipolar disorder, as confirmed through a clinical interview
  • People who are already receiving a specific type of PTSD therapy (called exposure-based treatment, such as Written Exposure Therapy, Prolonged Exposure, or Cognitive Processing Therapy) through another provider
  • People who are currently incarcerated — those individuals are only able to receive obstetric (pregnancy-related) care at BMC and are not permitted to receive mental health services outside of their correctional facility

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yael I Nillni, PhD, BUSM Department of Psychiatry and VA Boston Healthcare System

Phone: 781-413-6319

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
31 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinician Administered Scale for PTSD-5 (CAPS-5) at baseline; Clinician Administered Scale for PTSD-5 (CAPS-5) at 8 weeks; Clinician Administered Scale for PTSD-5 (CAPS-5) at 1 month postpartum; Clinician Administered Scale for PTSD-5 (CAPS-5) at 6 months postpartum; Clinician Administered Scale for PTSD-5 (CAPS-5) at 12 months postpartum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov